Evoke Wealth’s Abeona Therapeutics ABEO Stock Holding History

Evoke Wealth’s Portfolio ABEO Stock Details ABEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-23	Closed	-$1.27K	–	1252
2019 Q3	$1.27K	Buy	+23	New	+$1.72K	﹤0.01%	1281

Other funds holding ABEO

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Evoke Wealth's ABEO Position: Q4 2019 in Review

Evoke Wealth sold out of Abeona Therapeutics (ABEO) in Q4 2019, closing a stake of 23 shares — an estimated $1.27K sold.

Evoke Wealth first reported a position in ABEO in Q3 2019 and held it in 1 quarter. The position peaked at $1.27K in Q3 2019. 87 funds tracked by Wall St. Rank hold ABEO as of Q4 2019.

Evoke Wealth reported no remaining Abeona Therapeutics position as of Q4 2019 after selling out during the quarter.
Evoke Wealth sold 23 Abeona Therapeutics shares in Q4 2019, an estimated $1.27K.
Evoke Wealth first reported a position in Abeona Therapeutics in Q3 2019 and held it in 1 quarter.
Evoke Wealth's Abeona Therapeutics position peaked at $1.27K in Q3 2019.
87 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2019.

Based on Evoke Wealth's 13F filing for Q4 2019, filed 7 Feb 2020.